NEW YORK (Reuters Health) – The average of five or six blood pressure measurements are needed in order to classify patients with reasonable certainty as having blood pressure…
NEW YORK (Reuters Health) – Men with benign prostatic hyperplasia experience a similar reduction in urinary symptoms whether they’re treated with dutasteride or finasteride, according to the results…
NEW YORK (Reuters Health) – Tc-99m dimercaptosuccinic acid (DMSA) renal scanning is not an accurate test for identifying children with dilating vesicoureteral reflux (VUR), suggest results of a…
NEW YORK (Reuters Health) – In pregnancy, antiepileptic drug (AED) polytherapy that includes valproate poses a higher risk of fetal malformations than therapy without this drug, according to…
NEW YORK (Reuters Health) – For patients with severe uncontrolled asthma, adding inhaled tiotropium to standard treatment improves lung function significantly, according to a study published June 3rd…
NEW YORK (Reuters Health) – Patients with persistent oligoarticular juvenile idiopathic arthritis (JIA) are unexpectedly at high risk for growth retardation, Israeli researchers report in a May 30th…
NEW YORK (Reuters Health) – A comparison trial conducted in Taiwan indicates that silodosin improves lower urinary tract symptoms associated with benign prostatic hyperplasia at least as well…
NEW YORK (Reuters Health) – When asymptomatic patients with a supratherapeutic INR are seen in the emergency department, can they be treated as outpatients or should they be…
NEW Y ORK (Reuters Health) – For patients with rheumatoid arthritis, the selective T-cell co-stimulation modulator abatacept works just as well whether administered subcutaneously (SC) once a week…
NEW YORK (Reuters Health) – In a small preliminary study, a combination pill containing 85 milligrams of sumatriptan and 500 milligrams of naproxen sodium formulated in a rapid…